Riskpilot← Back to searchSign inGet full accessPFIZER AS
ASActiveOrg 915213596Drammensveien 288, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 195969 employees
Revenue 2024
NOK 974,5M
-16% vs 2023
EBITDA margin
2.5%
+91% vs 2023
Equity ratio
31.1%
Financial strength
Net profit 2024
NOK 32,9M
+51% vs 2023
| Revenue | NOK 974,5M | -16% |
| EBITDA | NOK 24,3M | +91% |
| Net profit | NOK 32,9M | +51% |
| Total assets | NOK 953,4M | -17% |
| Equity | NOK 296,4M | -36% |
| Employees | 69 | — |
Legal name
PFIZER AS
Org number
915213596
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. november 1959
Share capital
NOK 216 451 221
Employees
69 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Address
Drammensveien 288, 0283 Oslo
Phone
+4767526100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 403 513 | 1 913 687 | 2 013 570 | 1 165 506 | 974 528 |
| Staff expenses | −72 397 | −180 866 | −179 566 | −195 841 | −187 933 |
| EBITDA | 30 570 | 98 171 | 63 739 | 12 750 | 24 320 |
| Depreciation & amort. | −7 221 | −6 673 | −3 678 | −3 682 | −5 663 |
| EBIT | 23 349 | 91 498 | 60 061 | 9 068 | 18 657 |
| Net financials | 254 | −9 125 | 29 124 | 19 702 | 24 118 |
| Profit before tax | 23 603 | 82 373 | 89 185 | 28 770 | 42 775 |
| Tax | 5 118 | 18 604 | 20 542 | 7 003 | 9 890 |
| Net profit | 18 485 | 63 769 | 68 643 | 21 767 | 32 885 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 258 340 | 855 365 | 1 332 958 | 1 142 999 | 953 435 |
| Equity | 114 568 | 375 816 | 444 514 | 465 781 | 296 364 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 108 402 | 433 303 | 845 287 | 575 634 | 611 939 |
| Total debt | 108 402 | 433 303 | 845 287 | 575 634 | 611 939 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
31.1%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
11.1%
This company
18.4%
Market median
+40% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
2.22×
This company
0.62×
Market median
-258% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-12-01 – 2020-11-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CS Deputy Member | Deputy Member | 2025 |
IH Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
AG Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (3) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2025 – 2025 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Pfizer Luxembourg Global Holdings S | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PFIZER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cathrine Simonsen Notland | Deputy Member | 0 companies |
| Ingvil Holth | Chief Executive Officer | 0 companies |
| Ahmet Giray Olmez | Chief Executive Officer | 0 companies |
| Glenn Aage Bjånesøy Osnes | Board of Directors | 0 companies |
| Erik Hjelvin | Chairman | 0 companies |
| Glenn Aage Osnes | Board of Directors | 0 companies |
| Ingrid Elisabeth Jebsen | Chairman | 0 companies |
| Sissel Lønning Andresen | Chairman | 0 companies |